Climb Global Solutions, Inc. (CLMB)

Regulus Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Regulus Therapeutics stock has a target of 136, which predicts a 25.96% increase from the current stock price of 107.98.

Price Target: $136.00 (+25.96%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$136	$136	$136	$136
Change	+25.96%	+25.96%	+25.96%	+25.96%

Analyst Ratings

According to 1 stock analyst, the rating for Regulus Therapeutics is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Vincent Colicchio Barrington Research	Barrington Research	Buy Maintains $136	Buy	Maintains	$136	+25.96%	Jul 25, 2025
Vincent Colicchio Barrington Research	Barrington Research	Buy Maintains $136	Buy	Maintains	$136	+25.96%	May 13, 2025
Vincent Colicchio Barrington Research	Barrington Research	Buy Maintains $136	Buy	Maintains	$136	+25.96%	Apr 24, 2025
Vincent Colicchio Barrington Research	Barrington Research	Buy Maintains $136	Buy	Maintains	$136	+25.96%	Mar 6, 2025
Vincent Colicchio Barrington Research	Barrington Research	Buy Maintains $136	Buy	Maintains	$136	+25.96%	Dec 12, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

554.18M

Increased by 19.02%

from 465.61M

Revenue Next Year

587.22M

Increased by 5.96%

from 554.18M

EPS This Year

5.59

Increased by 37.80%

from 4.06

EPS Next Year

6.38

Increased by 14.04%

from 5.59

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	251.57M	282.58M	304.35M	352.01M	465.61M	554.18M	587.22M	594.86M
Revenue Growth	20.51%	12.33%	7.70%	15.66%	32.27%	19.02%	5.96%	1.30%
EPS	1.01	2.09	2.81	2.72	4.06	5.59	6.38	6.92
EPS Growth	-32.93%	106.93%	34.45%	-3.20%	49.27%	37.80%	14.04%	8.39%
Forward PE	-	-	-	-	-	19.30	16.92	15.61
No. Analysts	-	-	-	-	-	4	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	573.2M	619.1M	612.4M
Avg	554.2M	587.2M	594.9M
Low	529.9M	550.6M	571.5M

Revenue Growth

Revenue Growth	2025	2026	2027
High	23.1%	11.7%	4.3%
Avg	19.0%	6.0%	1.3%
Low	13.8%	-0.7%	-2.7%

EPS Forecast

EPS	2025	2026	2027
High	6.12	6.78	7.12
Avg	5.59	6.38	6.92
Low	5.04	5.93	6.64

EPS Growth

EPS Growth	2025	2026	2027
High	50.8%	21.2%	11.6%
Avg	37.8%	14.0%	8.4%
Low	24.1%	6.0%	4.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.